Skip to content

Provention Bio, Inc.

CIK 0001695357

← back to feed
Revenue (TTM)
$2.76M
+824.4% YoY FY Mar 2023
Net Income (TTM)
−$107.31M
+0.8% YoY FY Mar 2023
EPS Diluted (TTM)
—
FY Mar 2023
Gross Margin
—
FY Mar 2023
Operating Margin
-4,169.2%
FY Mar 2023
Net Margin
-3,888.0%
FY Mar 2023
Free Cash Flow (TTM)
−$48.81M
FY Mar 2023
Cash
$44.04M
FY Mar 2023
Total Debt
$23.47M
FY Mar 2023
Shares Outstanding
94.78M sh
FY Mar 2023

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings